| Literature DB >> 35418820 |
Barbara Oleksy1, Hanna Mierzewska1, Jolanta Tryfon1, Maria Wypchło2,3, Krystyna Wasilewska2, Zofia Zalewska-Miszkurka1, Rafał Płoski2, Małgorzata Rydzanicz2, Elżbieta Szczepanik1.
Abstract
We report on the first Polish patient diagnosed with the Aicardi-Goutières syndrome 5 (AGS5). AGS is caused by mutations in one of 9 genes (TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, IFIH, LSM11, RNU7-1) which stimulate the type I interferon response. The diagnosis was confirmed by identifying a compound heterozygous mutation p.(Phe165Ser)/p.(Gln235*) in the SAMHD1 gene using whole-exome sequencing. The cystic lesions in the temporal lobes are an uncommon finding in the presented patient carrying a SAMHD1 mutation. Reporting new cases expands the range of phenotypes and plays the crucial role in understanding the AGS pathogenesis and creates new therapy approaches.Entities:
Keywords: Aicardi-Goutières syndrome; Interferonopathy; Magnetic resonance imaging; SAMHD1; Temporal white matter cysts
Year: 2021 PMID: 35418820 PMCID: PMC8928195 DOI: 10.1159/000518941
Source DB: PubMed Journal: Mol Syndromol ISSN: 1661-8769